BioSpace News Archive

To meet stringent regulatory requirements, such as the United States Pharmacopeia (USP), National Formulary (NF) or FDA, as well as production and budgetary demands, pharmaceutical manufacturers require high-volume precision blending of formulations on equipment that provides exceptional batch-to-batch consistency and repeatable results.

The American Association of Colleges of Osteopathic Medicine (AACOM) has launched the Choose DO Explorer, the Association’s first online search tool created for prospective students and health professions advisors.

U.S. Patent Office and European Patent Office issue allowances of patent applications relating to iduronate-2-sulfatase (“IDS”) polypeptide/xB3 conjugates

Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplant to more patients, today announced that it has appointed Anne McGeorge, M.S., CPA, to its board of directors.

Research led by Consortia TX Founders underscores the potential for microbial therapeutics for food allergies

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced the closing of its initial public offering of 9,109,725 shares of common stock at a public offering price of $17.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to 1,188,225 additional shares of common stock.

Calyxt, Inc. (NASDAQ: CLXT), a healthy food ingredients company, today announced that it has entered into a commercial crushing agreement with Landus Cooperative, significantly expanding Calyxt’s network of processing partners.

Terns Pharmaceuticals, Inc. today announced an exclusive licensing and collaboration agreement with GENFIT (GNFT), a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver-related diseases.

The data reported a 99% technical success rate for 20 gage FNB needles even though a “significant number of lesions were sampled from an angulated endoscope position, including pancreatic head masses.”

MHRA again confirmed its positive scientific opinion for idebenone under the EAMS while a corresponding European marketing authorization application (MAA) has recently been submitted.